Welcome New Members November 2020!

Posted by ISPE Boston
On December 7, 2020

We would like to introduce the Members who joined ISPE in November 2020, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Alnylam Wins FDA Approval for RNAi Treatment for Rare Kidney Disease

Posted by ISPE Boston
On December 3, 2020

Alnylam Pharmaceuticals has announced FDA approval for lumasiran (brand name Oxlumo), a RNAi therapeutic for PH1 (primary hyperoxaluria type 1), an ultra-rare genetic disease characterized by oxalate overproduction. The excess production of oxalate results in the deposition of calcium oxalate crystals in the kidneys and urinary tract and can lead to the formation of painful […]

Agios Phase 3 Trial Shows Positive Results for Anemia Drug

Posted by ISPE Boston
On December 3, 2020

Agios Pharmaceuticals has announced that its global Phase 3 ACTIVATE trial of mitapivat met its primary endpoint. ACTIVATE is a double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of mitapivat as a potential treatment for adults with pyruvate kinase (PK) deficiency, a chronic, lifelong hemolytic anemia, who do not receive regular transfusions. Treatment with […]

Biogen and Sage Therapeutics in Global Collaboration

Posted by ISPE Boston
On December 3, 2020

Biogen and Sage Therapeutics have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for major depressive disorder (MDD), postpartum depression (PPD) and other psychiatric disorders and SAGE-324 for essential tremor and other neurological disorders. “We are excited about the potential to bring together Biogen’s leading capabilities in neuroscience with Sage’s […]

A Thanksgiving Thank You…

Posted by ISPE Boston
On November 25, 2020

As this difficult year draws to a close and with Thanksgiving fast approaching, we give thought to the many things we are thankful for. Sharing their thoughts are a few of the Chapter board members: Eric Felz – “I am thankful for the people who support me. Support from family, friends, colleagues and staff allows me […]

A Thanksgiving Message from Board Member Howard Sneider

Posted by Howard Sneider
On November 25, 2020

As 2020 turns the corner toward the end of the year and with the Thanksgiving holiday upon us, I’m sure that many share the desire to (virtually) gather with friends and family and express their wishes for this awful year to be over. The scourge of a highly infectious and potentially lethal virus, coupled with […]

Women in Pharma Presents “Implicit Bias – Actions for Change”

Posted by Katherine Leitch
On November 23, 2020

Thank you to all who attended our Women in Pharma virtual educational event on October 28, 2020 as part of the Boston Area Chapter Fall Educational Summit. We were honored to have guest speaker Joanne Kamens PhD, Executive Director of Addgene, present on the important topic of “Implicit Bias – Actions for Change.” Dr. Kamens […]

Chapter Announces October Promo Membership Boost

Posted by ISPE Boston
On November 19, 2020

We would like to welcome all new and returning Boston Area Chapter ISPE members to the 2020-2021 program year! A special thank you and congratulations to our October Membership Promo winner: Michael Eaton from Vertex Pharmaceuticals. ISPE recognizes the vital role our members play in our development and mission. To show our gratitude and appreciation […]

Novartis Acquires Vedere Bio of Cambridge

Posted by ISPE Boston
On November 12, 2020

Vedere Bio, a stealth-stage company focused on advancing optogenetic therapies that are delivered to the retina to restore functional vision, has been acquired by Novartis. Shareholders in Vedere Bio received $150 million upfront and will be eligible for up to $130 million in milestone payments, for a total of $280 million. Vedere Bio was formed […]

Sartorius to Expand in MA, Create 100 Jobs in Marlborough

Posted by ISPE Boston
On November 12, 2020

Sartorius is expanding its presence in Massachusetts with a 40,000-square-foot North American Customer Interaction Center in Marlborough that will open in early 2021. The Customer Interaction Center initiative will enable Sartorius to scale up its operations and capabilities in the Boston biotech hub. The new site in Marlborough also will provide the capacity to support […]

Page 56 of 118«‹54 555657 58 ›»